Founders & Core Team

 
AMY_BELT_B&W

Amy Belt Raimundo

Amy Raimundo is a Vice President at Covidien Ventures and head of the West Coast office. Her experience spans 18 years of venture capital, medical device operations, and healthcare consulting. Prior to joining Covidien, Amy was a Vice President with Advanced Technology Ventures (ATV), a venture capital firm in Palo Alto, CA. She focused on investments in the medical device sector. Before ATV, Amy was at Guidant Corporation (later Abbott Vascular) where she led the international launch of the Xience drug eluting stent, as well as launched and managed products in the U.S., Europe, and Asia. She began her career as a Management Consultant for APM/CSC Healthcare, optimizing clinical guidelines, operations, and strategy for approximately 40 hospitals. Amy holds an MBA from the Walter Haas School of Business at the University of California at Berkeley and a BA in Economics from Yale University. She is also a Kauffman Venture Fellow.

Deborah Kilpatrick_B&W

Deborah Kilpatrick, PhD

Deborah Kilpatrick is the Chief Commercial Officer of CardioDx with responsibilities for sales and marketing to providers and payers. CardioDx has been honored by the Wall Street Journal, TIME Magazine, and the Edison Awards, and was on the 2012 Fierce15 list of most promising privately-held med tech companies. Prior to joining CardioDx, Deb held various roles within Guidant Corporation’s Vascular Intervention Division, including Research Fellow, Director of R&D, and Director of New Ventures. Early in her career, Deb was a structural engineer at Pratt and Whitney on the F22 Raptor program. She currently serves on Advisory Boards for Georgia Tech, is on the Board of Directors for the Dystonia Medical Research Foundation, and is a Fellow of the American Institute of Medical and Biological Engineering. Deb holds multiple US patents, and she received her BS in Engineering Science and Mechanics and both MS and PhD degrees in Mechanical Engineering from the Georgia Institute of Technology.

Amanda_Depalma_B&W

Amanda DePalma

Amanda DePalma is Senior Director of Global Strategic Marketing at Edwards Lifesciences in Irvine, CA, where her responsibilities include strategic planning and brand management. She has been in medical device marketing and sales for more than 17 years working at leading companies such as Guidant Corporation, Abbott Vascular, and Kimberly-Clark Healthcare. Amanda is passionate about delivering clinical solutions to improve the lives of patients and clinicians. She received her MBA from the University of Florida Warrington College of Business.

Bridget Hurley_B&W

Bridget Hurley

Bridget Hurley is currently the R&D Director for Abbott Vascular Structural Heart based in Menlo Park. Bridget has over 15 years of medical device experience, both in product development and clinical trial management. Bridget joined the Vascular Intervention division of Guidant Corporation in 1998 and played an integral role in the design and development of the XIENCE V drug-eluting stent program. In 2006, Bridget transferred to Brussels, Belgium with Abbott Vascular, and as the Director for EMEA Clinical Operations supported the international clinical trials for coronary and endovascular applications. Bridget holds a BS in Mechanical Engineering from The University of Texas at Austin, and an MS in Mechanical Engineering from Georgia Institute of Technology.

JacquéAshby_B&W

Jacqué Ashby

Jacqué Ashby is an Executive Assistant, Independent Event Manager, and Personal Chef. Prior to Aptus, she spent four years at FlowCardia/BPV, five years at Kyphon, and two years at Arthrocare, where her various roles included Executive Assistant, Sales Support Supervisor, and CSR. Through these various roles, a passion developed for Event Planning and Management of all meeting types, domestically and internationally: industry tradeshows, board meetings, sales meetings, incentive trips, physician advisory board, etc. Jacqué is multi-lingual, holds a BA in French w/ a German minor from SJSU, a Culinary Arts Diploma from PCI, now FCI California, and is the recipient of the Bert Cutino Award for Culinary Excellence.

Jennifer T. Beedon_B&W

Jennifer T. Beedon

Jennifer Beedon partners with companies to evaluate and prioritize opportunities for growth. She brings 15 years of operational experience to her clients, which include medical device start-ups as well as Fortune 500 companies. Before starting her own firm, Jennifer was at Guidant Corporation where she identified, recommended, and executed several key business alliances. She managed Guidant’s strategic alliance with Johnson & Johnson to copromote the CYPHER sirolimus-eluting stent, including all sales support. Prior to earning her MBA, Jennifer spent five years working in operations at 3M Company, holding both domestic and international leadership positions. She brings cross-disciplinary experience in product development, manufacturing, business development, and marketing. Jennifer holds an MBA from Harvard Business School and a BS in Chemical Engineering from the University of Michigan.

Jessica Hudak_B&W

Jessica Hudak

Jessica Hudak, a registered patent agent, specializes in working with medical device start-up companies. Prior to founding Hudak Consulting Group LLC, Jessica served as Sr. Intellectual Property Manager for Baxano, Inc. (to be acquired by TranS1 Inc.) from 2008 to 2012. Prior to moving in house, Jessica worked as a patent agent for ShayGlenn LLP where her practice focused on medical device technology in multiple clinical areas for early-stage companies. Jessica was also Schox Patent Group’s Senior patent agent from 2004 to 2008. In September of 2006, Jessica graduated from the Stanford Biodesign Innovation Fellowship Program. Jessica currently serves as President of The Biodesign Alumni Association. Jessica received her MS in Biomechanical Engineering from Stanford University and her BS (magna cum laude) in Mechanical Engineering from the University of Michigan. As a mechanical engineer, Jessica interned for IDEO in 2006, Ethicon Endo-Surgery in 2004, and Stryker Instruments in 2003.

Laura Parmer-Lohan_B&W

Laura Parmer-Lohan

Laura Parmer-Lohan is a b-to-b and consumer marketing executive with experience in diagnostics, pharmaceuticals, and medical devices. Currently, she heads up marketing and customer service for diaDexus, a cardiovascular diagnostic leader that saves lives by finding hidden risk for heart attack and stroke. At Genoptix—A Novartis Co., she oversaw efforts which yielded the highest number of test service launches in the company’s history. Prior to this, she served as a marketing director for Amylin Pharmaceuticals where she led the consumer brand for the launch of BYETTA®—a treatment for type 2 diabetes and helped the company grow from $85MM in milestone payments to more than $750MM in annual revenue. Laura spent six years at Guidant Corp. (now Abbott Vascular) in various marketing positions, all with increasing responsibilities. She earned her BA from UCSC and an MBA from UC Berkeley, Haas School of Business.

Natalie_shlafam_B&W

Natalie Shlafman

Natalie Shlafman is senior director of managed care and product marketing at CardioDx, a cardiovascular genomic diagnostics company in Palo Alto, California. Prior to joining CardioDx, Natalie was in the Vascular Intervention Division of Guidant Corporation, where she worked in market development within the New Ventures unit and in product marketing within the Angioplasty Systems group. Natalie received her MBA from the Kellogg School of Management at Northwestern University. Prior to her MBA, Natalie worked in the high-tech industry and held product marketing roles at LogicTier and at SGI. Natalie received her BA in psychology with a business specialization from UCLA.

nicole_omser_B&W

Nicole Osmer

Based in Menlo Park, California, Nicole Osmer is a public relations expert specializing in med-tech communications. Prior to starting her own health care public relations practice, Nicole managed external communications for Guidant’s stent and cardiac surgery divisions for several years, playing a central role in numerous major announcements. Nicole’s clients include Abbott Vascular, Advanced Cardiac Therapeutics, Autonomic Technologies, CardioKinetix, CardioDx, HeartFlow, Intersect ENT, Tryton Medical, and Nevro Corp. She holds a BA from the University of Wisconsin-Madison.

headshots_0000s_0042_Susan-St

Susan Stimson

Ms. Stimson has wide-ranging expertise in the medical device business in both large and start-up companies. She currently runs Marketing & Customer Service for Intersect ENT and has played a key role in building the company from its early stage to a commercial business.  Prior to that, she served as Director of Marketing & Clinical Research for start-up heart valve company Mitralign. In her many years at Guidant, Ms. Stimson impacted top-priority products from the aspects of marketing, sales and R&D, effectively leading teams to design best-in-class products and launching them successfully in worldwide markets.  Ms. Stimson holds a BS in biomedical engineering from Marquette University.

Tamara Elias_B&W

Tamara Elias, MD

Tamara Elias, MD, is a Partner at Essex Woodlands, a global healthcare-only growth equity firm with $2.5B under management. She brings over 15 years of healthcare experience to the firm, which she joined in 2007. Tamara serves on the Boards of Millennium Pharmacy Systems, a technology-based, long-term care pharmacy, BreatheAmerica which oversees outpatient clinics focused on the management of chronic airway diseases, as well as Medseek, the leading provider of online strategic patient engagement solutions for hospitals. Previously, she served on the board of ATS Medical, which was sold to Medtronic for $370 million in 2010. Prior to Essex Woodlands, Tamara spent six years at McKinsey as a senior engagement manager and was a general surgery resident at Massachusetts General Hospital after receiving her MD at Johns Hopkins School of Medicine. Tamara is also a Kauffman Venture Fellow.

virginia_giddings_B&W

Virginia L. Giddings, PhD

Virginia Giddings heads Strategic R&D at Abbott Nutrition, with the responsibility for leading global R&D to deliver innovative science and technology into globally launched nutrition products. Her experience spans over 20 years in developing healthcare solutions, including in pharmaceuticals and medical devices. Previously at Abbott, she held roles leading Partner and Vascular Product Development, including XIENCE and ABSORB, which was named as R&D Magazine’s 2013 top 100 technologies. She had IP strategy roles with J&J ALZA, as well as consulting with Exponent. She started her career as an orthopaedic design engineer at the Hospital for Special Surgery. She currently serves on an Advisory Board for Cornell University. She is a registered patent agent and earned a BS and an ME in Mechanical Engineering from Cornell and a PhD in Orthopaedic Biomechanics from Stanford.

Organizing Committee

 
Azadeh_nasibi_B&W

Azadeh Nasibi

Azadeh Nasibi is a Director of Strategy and Business Development at Covidien Vascular Therapies’ Neurovascular division. Her responsibilities include market opportunity analysis, deal evaluation and due diligence, and strategic planning for the Neurovascular business, located in Irvine, CA. Prior to joining Covidien, Azadeh was a Manager in Deloitte Consulting’s Life Sciences practice, specializing in Strategy and Operations, consulting for Biotech and Medtech clients ranging from start-ups to Fortune 500 corporations. She holds an MBA from the Anderson School of Management at the University of California at Los Angeles. Prior to her MBA, Azadeh worked in the high- tech industry as an IT consultant and software engineer. She received her BS in Information and Computer Science from the University of California at Irvine.

headshots_0000s_0032_Debbie-B

Debbie J. Baker

Debbie has 30+ years of financial experience in the healthcare industry and is responsible for originating financings for life sciences companies in western North America. Before joining Oxford, Debbie was executive VP for Capital Advisors Group, providing investment management services to life sciences and medical device companies. She has held positions as business development director for Questpoint, treasurer for MFS Intelenet, assistant treasurer at ASK Computer Systems, VP of Corporate Finance & Debt for Sierra Capital Companies and treasurer for Consolidated Capital. Debbie received her BA in speech communications and an MBA from University of Denver.

Janie Mandrusov

Janie Mandrusov, PhD

Janie Mandrusov, PhD, is a director of Preclinical and Clinical Development at SinuSys Corp., an early-stage start-up that develops new therapies to improve the sinus health of patients. Before joining SinuSys, Janie was a Director of Preclinical and Emerging Clinical Research at ArthroCare Corp., a multibusiness medical device company that develops products for ENT, Sports Medicine, and Spine Therapies. Prior to that, she was Vice President of Preclinical and Clinical Development at Synvascular Inc., a start-up anastomosis company. Janie joined the medical devices industry more than 15 years ago as a scientist with Guidant Corp. (now Abbott Vascular). Here she spent 10 years in roles of increasing leadership responsibility in R&D department, developing novel technologies for the treatment of Heart Failure and Vulnerable Plaque. Janie also works closely with the SJSU Biomedical Engineering Department as an industry student advisor and a member of the organizing committee for Bay Area Biomedical Device Conference. Janie holds a PhD degree in Chemical Engineering from Columbia University and a BS degree in Bioengineering from UCSD.

Katie Arnold_B&W

Katie Arnold

Katie Arnold has 20 years of experience in healthcare and has worked with a variety of medical technology companies ranging from venture-backed start-ups to Fortune 500 companies. Katie founded and leads SPRIG Consulting, LLC providing strategic marketing services. Her capabilities range from business plan refinement and market opportunity assessments to development of marketing strategies that include corporate/product positioning and brand development. Katie has demonstrated an aptitude for delivering flawless launch execution and commercialization strategy implementation in the US, EU, and AP geographies. During her tenure, Katie is proud to have named over a dozen (and counting) medical products. Prior to founding SPRIG, Katie’s career included sales and marketing roles with Guidant Corporation and Kensey Nash Corporation. Katie holds an MBA from Northwestern University’s Kellogg Graduate School of Management and a BA from the University of Vermont.

Leslie Oley_B&W

Leslie Oley

Leslie Oley is currently a marketing manager at ApniCure, with responsibility for product strategy and marketing for a novel obstructive sleep apnea therapy. Previously, Leslie applied her cross-disciplinary experience in marketing, clinical, and product development as a consultant with several early-stage Medtech companies that were focused on product introduction in both the US and China. She was formerly a Senior Marketing Manager for Voyage Medical, where she played a key role in the development of a direct visualization cardiac ablation system and the execution of an OUS clinical feasibility trial. Leslie began her career working with Boston Scientific’s Electrophysiology division, where she held both R&D and Product Management roles. She earned a BS in Mechanical Engineering from Penn State University, and an MS in Mechanical Engineering from Stanford University, where she conducted NSF-funded research in cardiovascular mechanics.

Lynn Edwards_B&W

Lynn Edwards

Lynn Edwards is Sr. Director of Strategic Marketing for Transcatheter valves at Edwards Lifesciences in Irvine, CA, where her responsibilities include strategic planning, business development, and day-to-day program management for the transcatheter business unit. Prior to joining Edwards in 2006, she was Vice President of Business Planning and Development at Walt Disney Imagineering and spent over 10 years as a management consultant with Corporate Decisions and Accenture, working primarily with clients in the pharma industry on pre- and post-merger integration. Lynn received a BA from Wheaton College and an MBA from the University of Chicago.

Becky Lai_B&W

Rebecca Lai

Rebecca Lai has over 14 years of experience in the medical device industry, both domestically and internationally. She currently consults for emerging medical technology companies specializing in organizational transformation, strategic planning, and tactical execution from clinical through commercial stages. Previously, Becky held sales and marketing leadership roles at Medtronic in the cardiac rhythm, patient and data management, and atrial fibrillation businesses. Her global work spans across both developed and emerging markets, including a two-year assignment in Johannesburg, South Africa. At Medtronic, she worked as a change agent through times of growth and decline by driving customer focus and creating paths of efficiency from development to sales. Becky is passionate about leading teams to bring breakthrough technologies and solutions to new markets. She earned a BSE and MSE in Bioengineering from the University of Pennsylvania.

Saatchi Sanaz_B&W

Sanaz Saatchi

Sanaz Saatchi is a Principal R&D Engineer at Medtronic, focusing on cardiovascular medical device innovation. After leading a global research effort exploring an area of opportunity, she gathered organizational support to successfully advance an early phase R&D project into product development. Currently, she is the technical lead on a cross-functional team driving multiple product concepts towards commercialization. Sanaz also serves as a manager to engineers providing career guidance.

Prior to Medtronic, Sanaz completed a PhD in Bioengineering at Stanford University, an MS in Mechanical Engineering at MIT, and a BS in Bioengineering at UC Berkeley. As a National Science Foundation Graduate Research Fellow, her background includes cardiovascular and orthopaedic research with multiple peer-reviewed journal publications and book chapters. Her prior industry experience includes two years at Becton Dickinson (BD) and consulting experience at a start-up and venture capital firm.

Terri-Burke_BW_rev

Terri L. Burke

Terri Burke leads Marketing & Business Development for Edwards’ $700M Heart Valve Therapy business, which includes nearly 40 heart valve products with more than 15 unique brands. In this role, she has responsibility for new product development pipeline marketing, branding, and business development. Burke also led Strategic Marketing for Edwards’ percutaneous structural heart disease initiatives. Prior to joining Edwards in 2006, Burke sourced, evaluated, and participated in Medtech investments with a venture capital firm. Burke also held a variety of positions in global and US marketing with Guidant Corporation and as a consultant with Covance Health Economics and Outcomes Services. She holds a BS in biology from Duke University and an MBA from the University of Southern California.